Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pulmatrix, Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
27
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'05'06'07'08'12'13'14'15'16'17
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
Pulmatrix, Inc. its own name
US, as the owner printed on each patent
20 publishedPulmatrix, Inc. its own name
named as the applicant on its applications, in US
7 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 9, 2017 | 9,642,798 | Monovalent metal cation dry powders for inhalation | Pharmaceuticals | Pulmatrix, Inc. |
| Sep 6, 2016 | 9,433,576 | Cationic dry powders | Pharmaceuticals | Pulmatrix, Inc. |
| Jan 12, 2016 | 9,233,158 | Dry powder formulations and methods for treating pulmonary diseases | Pharmaceuticals | Pulmatrix, Inc. |
| Jun 23, 2015 | 9,061,352 | Dry powder formulations and methods for treating pulmonary diseases | Pharmaceuticals | Pulmatrix, Inc. |
| Mar 31, 2015 | 8,992,983 | Respirably dry powder comprising calcium lactate, sodium chloride and leucine | Pharmaceuticals | Pulmatrix, Inc. |
| Jun 24, 2014 | 8,758,824 | Respirably dry powder comprising calcium lactate, sodium chloride and leucine | Pharmaceuticals | Pulmatrix, Inc. |
| Jan 14, 2014 | 8,627,821 | Method and device for decreasing contamination | Analysis of biological materials | Pulmatrix, Inc. |
| Nov 26, 2013 | 8,591,866 | Formulations decreasing particle exhalation | Pharmaceuticals | Pulmatrix, Inc. |
| May 29, 2012 | 8,187,637 | Formulations decreasing particle exhalation | Pharmaceuticals | Pulmatrix, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| May 5, 2016 | 2016/0120855 | TIOTROPIUM DRY POWDERS | Pharmaceuticals | Pulmatrix, Inc. · patent 9,737,518 granted from it |
| Sep 10, 2015 | 2015/0250875 | DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES | Pharmaceuticals | Pulmatrix, Inc. · patent 9,233,158 granted from it |
| Aug 20, 2015 | 2015/0231066 | MONOVALENT METAL CATION DRY POWDERS FOR INHALATION | Pharmaceuticals | Pulmatrix, Inc. |
| Jul 23, 2015 | 2015/0202227 | RESPIRABLY DRY POWDER COMPRISING CALCIUM LACTATE, SODIUM CHLORIDE AND LEUCINE | Pharmaceuticals | Pulmatrix, Inc. |
| Jul 16, 2015 | 2015/0196589 | FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING | Pharmaceuticals | Pulmatrix, Inc. |
| Jul 16, 2015 | 2015/0196486 | DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES | Pharmaceuticals | Pulmatrix, Inc. · patent 9,119,778 granted from it |
| May 21, 2015 | 2015/0136130 | INHALABLE DRY POWDERS | Pharmaceuticals | Pulmatrix, Inc. |
| Mar 19, 2015 | 2015/0079173 | FORMULATIONS DECREASING PARTICLE EXHALATION | Pharmaceuticals | Pulmatrix, Inc. |
| Jan 1, 2015 | 2015/0004233 | RESPIRABLY DRY POWDER COMPRISING CALCIUM LACTATE, SODIUM CHLORIDE AND LEUCINE | Pharmaceuticals | Pulmatrix, Inc. · patent 8,992,983 granted from it |
| Nov 13, 2014 | 2014/0336159 | METHODS FOR TREATING AND DIAGNOSING RESPIRATORY TRACT INFECTIONS | Pharmaceuticals | Pulmatrix, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.